Netspot Kit
NDC Package 69488-001-40
Package Information
Netspot (68ga-dotatate) kits is nETSPOT, after radiolabeling with Ga 68, is indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients. This formulation utilizes a kit delivery system. Marketed by Advanced Accelerator Applications Usa, Inc, this product is identified by NDC 69488-001 and is authorized under FDA application NDA208547.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69488 - Advanced Accelerator Applications Usa, Inc
- 69488-001 - Netspot
- 69488-001-40 - 1 KIT in 1 KIT * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
- 69488-001 - Netspot
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69488-001-40 identifies a specific commercial package of 1 kit in 1 kit * 1 injection, powder, lyophilized, for solution in 1 vial, single-dose of Netspot, a human prescription drug labeled by Advanced Accelerator Applications Usa, Inc. This kit is formulated for intravenous use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Advanced Accelerator Applications Usa, Inc on June 01, 2016. The current certification is valid through December 31, 2027.
How is this Advanced Accelerator Applications Usa, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69488000140. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
